An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

Phase 2UnknownNCT00825942

Chakshu Research, Inc.20 enrolled

Overview

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Asteroid Hyalosis

Interventions

C-KAD Ophthalmic SolutionDRUG

4 drops applied daily for 180 days

Eligibility

Sex: ALLMin age: 21 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Presence of asteroid hyalosis Exclusion Criteria: * Active ocular infection * Glaucoma * Ocular hypertension * Ocular inflammatory disorders

Locations (1)

Mountain View Optometry and Contact Lens Clinic

Mountain View, California, United States

Outcomes

Primary Outcomes

Reduction in the number of asteroid bodies

Time frame: 180

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.